Generic Drug Makers Preparing To Make Japanese Utilization Goal A Reality
This article was originally published in PharmAsia News
Executive Summary
TOKYO - The Japan Generic Medicines Association released survey results July 9 saying its 40 member companies are gearing up to manufacture considerably more generics in the next few years. Generic drug makers say they are meeting expectations set by the Ministry of Health, Labour and Welfare to raise Japan's generic drug use share for prescriptions from the current 17 percent to the government goal of 30 percent by fiscal year 2012
You may also be interested in...
Japan Vows Anew To Overcome Reluctance To Boost Generics Use
Despite slow adoption, the potential for massive shift in Japan’s branded-generics market is a draw for foreign firms as policymakers see increased usage as key to containing health costs.
Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi In Hot Pursuit Of Sources Of Innovation in Asia: An Interview with PharmAsia News
During the last few weeks Roche has been in hot pursuit of sources of innovation, including the proposed acquisition of partner Genentech. In the same week it acquired antibody screening company Arius, RNAi company Mirus and made three more deals that the company will not announce. Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi sat down with the PharmAsia News Australia bureau to discuss what Roche is looking for in its partners and its current partnership with Roche's Japan partner Chugai.
Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi In Hot Pursuit Of Sources Of Innovation in Asia: An Interview with PharmAsia News
During the last few weeks Roche has been in hot pursuit of sources of innovation, including the proposed acquisition of partner Genentech. In the same week it acquired antibody screening company Arius, RNAi company Mirus and made three more deals that the company will not announce. Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi sat down with the PharmAsia News Australia bureau to discuss what Roche is looking for in its partners and its current partnership with Roche's Japan partner Chugai.